Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Olodaterol und Tiotropiumbromid (ATC-Code: R03AL06).

Conclusion of a non-exclusive discount contract under § 130a para. 8 SGB V for medicinal products with the active substance combination of olodaterol and tiotropium bromide (ATC code: R03AL06) for the period from 01.08.2026 to 31.07.2028, with the possibility of concluding the contract at any time during the contract period (open-house model).